Vimarsana
Biggest News Aggregation in the World

Nod For News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nod For. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nod For Today - Breaking & Trending Today

Delhi Women's Body Head Swati Maliwal Seeks Foreign Minister's Nod For Harvard Visit - Vimarsana News

Delhi Women's Body Head Swati Maliwal Seeks Foreign Minister's Nod For Harvard Visit

Delhi Commission For Women chief Swati Maliwal on Thursday requested Union External Affairs Minister S Jaishankar to clear the file pertaining to her visit to the US to attend a conference on February 11.

Source: ndtv.com
Angela Bassett Scores 2023 Oscar Nod For 'Wakanda Forever' - Vimarsana News

Angela Bassett Scores 2023 Oscar Nod For 'Wakanda Forever'

On Tuesday, Angela Bassett was nominated for an Oscar in the category of Best Supporting Actress for her role as Queen Ramonda in 'Black Panther: Wakanda Forever.' Bassett is considered to be the favorite to win after recently winning the Critics Choice and Golden Globe Awards. The post Angela Bassett Scores 2023 Oscar Nod For ‘Wakanda Forever’ appeared first on The Latest Hip-Hop News, Music and Media | Hip-Hop Wired.

Ground News - Amazon wins EU antitrust nod for $8.5 bln MGM deal - Vimarsana News

Ground News - Amazon wins EU antitrust nod for $8.5 bln MGM deal

Amazon on Tuesday gained unconditional EU antitrust approval for its proposed $8.5 billion acquisition of U.S. movie studio MGM to help it to compete with streaming rivals Netflix and Disney+ .

LIC Gets Market Regulator SEBI's Nod For IPO: Report - Vimarsana News

LIC Gets Market Regulator SEBI's Nod For IPO: Report

India's market regulator has approved state-owned Life Insurance Corp's (LIC) initial public offering worth about $8 billion, TV channel ET Now reported on Wednesday, citing sources.

Source: ndtv.com
Coronavirus Vaccine Booster Dose: Biological E Seeks Regulator's Nod For Phase-3 Trial Of Corbevax As Booster Dose - Vimarsana News

Coronavirus Vaccine Booster Dose: Biological E Seeks Regulator's Nod For Phase-3 Trial Of Corbevax As Booster Dose

Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.

Source: ndtv.com